{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:25:10Z","timestamp":1790965510388,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011640","name":"European Neuromuscular Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.nmd.2011.03.013","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T17:14:07Z","timestamp":1304788447000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Myotonic dystrophy type 2 (DM2) and related disorders"],"prefix":"10.1016","volume":"21","author":[{"given":"B.","family":"Udd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Meola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Krahe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Wansink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bassez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Moxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2011.03.013_b0005","series-title":"Myotonic Dystrophy","author":"Harper","year":"1989"},{"issue":"3","key":"10.1016\/j.nmd.2011.03.013_b0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.410350305","article-title":"Myotonic dystrophy with no trinucleotide repeat expansion","volume":"35","author":"Thornton","year":"1994","journal-title":"Annal Neurol"},{"issue":"8","key":"10.1016\/j.nmd.2011.03.013_b0015","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1212\/WNL.44.8.1448","article-title":"Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts","volume":"44","author":"Ricker","year":"1994","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2011.03.013_b0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0960-8966(97)00041-2","article-title":"Proximal myotonic dystrophy \u2013 a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes?","volume":"7","author":"Udd","year":"1997","journal-title":"Neuromus Disorder"},{"issue":"7","key":"10.1016\/j.nmd.2011.03.013_b0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0960-8966(98)00086-8","article-title":"Proximal myotonic myopathy (PROMM) and other proximal myotonic syndromes","volume":"8","author":"Moxley","year":"1998","journal-title":"Neuromus Disorder"},{"issue":"2","key":"10.1016\/j.nmd.2011.03.013_b0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/570","article-title":"Genetic mapping of a second myotonic dystrophy locus","volume":"19","author":"Ranum","year":"1998","journal-title":"Nature Genetics"},{"key":"10.1016\/j.nmd.2011.03.013_b0035","doi-asserted-by":"crossref","unstructured":"The International Myotonic Dystrophy Consortium (IDMC). New nomenclature and DNA testing guidelines for myotonic dystrophy type 1. Neurology 2000; 54:1218\u20131221.","DOI":"10.1212\/WNL.54.6.1218"},{"key":"10.1016\/j.nmd.2011.03.013_b0040","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/378566","article-title":"Verification of DM2 (CCTG)n expansion mutation and a single shared haplotype among PROMM\/PDM patients from different ethnic origins indicates ancestral founder effect","volume":"78","author":"Bachinski","year":"2003","journal-title":"Am J Hum Gen"},{"issue":"5531","key":"10.1016\/j.nmd.2011.03.013_b0045","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nmd.2011.03.013_b0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0960-8966(01)00284-X","article-title":"Ricker K: 84th ENMC: Proximal myotonic myopathy (PROMM) and other myotonic dystrophy like syndromes","volume":"12","author":"Moxley","year":"2002","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.nmd.2011.03.013_b0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0960-8966(03)00092-0","article-title":"115th ENMC: DM2\/PROMM and other myotonic dystrophies: 3rd workshop","volume":"13","author":"Udd","year":"2003","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.nmd.2011.03.013_b0060","doi-asserted-by":"crossref","unstructured":"Suominen T, Bachinski L, Auvinen S, Hackman P, Angelini C, Peltonen L, Krahe R, Udd B. Population frequency of myotonic dystrophy: Higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. EJHG 2011 (in press).","DOI":"10.1038\/ejhg.2011.23"},{"key":"10.1016\/j.nmd.2011.03.013_b0065","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/mus.21789","article-title":"Altered isoform usage for MADS-domain transcription enhancer factor 2 (MEF2) in myotonic dystrophy and other neuromuscular disorders","volume":"42","author":"Bachinski","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2011.03.013_b0070","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2353\/ajpath.2010.100179","article-title":"Mutant (CCTG)n expansion causes abnormal expression of ZNF9 in myotonic dystrophy type 2 (DM2)","volume":"177","author":"Raheem","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2011.03.013_b0075","doi-asserted-by":"crossref","first-page":"e9301","DOI":"10.1371\/journal.pone.0009301","article-title":"ZNF9 regulates IRES-mediated translation of the human ODC mRNA in myotonic dystrophy type 2","volume":"5","author":"Sammons","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2011.03.013_b0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-010-0637-6","article-title":"Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2","volume":"119","author":"Vihola","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"R1","key":"10.1016\/j.nmd.2011.03.013_b0085","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1093\/hmg\/ddq161","article-title":"Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function","volume":"19","author":"Mulders","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.nmd.2011.03.013_b0090","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2009.02942.x","article-title":"Side effects of anesthesia in DM2 as compared to DM1: a comparative retrospective study","volume":"17","author":"Kirzinger","year":"2010","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2011.03.013_b0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mus.20822","article-title":"Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)","volume":"36","author":"Moxley","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2011.03.013_b0100","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/01.WNL.0000065898.61358.09","article-title":"Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM\/DM2","volume":"60","author":"Vihola","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2011.03.013_b0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/mus.10545","article-title":"Muscle pathology in 57 patients with myotonic dystrophy type 2","volume":"29","author":"Schoser","year":"2004","journal-title":"Muscle Nerve"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896611001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896611001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:58:59Z","timestamp":1760774339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896611001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0960896611001106"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2011.03.013","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myotonic dystrophy type 2 (DM2) and related disorders","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2011.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}